Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 29, 2023
Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
November 15, 2023
During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...
SPEECHES
November 02, 2023
On October 30, 2023, CGD senior fellow Charles Kenny delivered remarks at the Oxford Martin School, where he is a visiting fellow. His speech, “The future of global development and implications for aid,” focused on global economic change and its impact on the development prospects of low- and middle...
WORKING PAPERS
October 11, 2023
Many countries are facing a much harsher budgetary prospect than a few years ago. For low- and middle-income countries in particular, domestic health expenditure is expected to plateau or contract (in real terms) for many until 2027, development assistance for health has already plateaued, and a deb...
Blog Post
October 11, 2023
Prior to the COVID-19 pandemic there were periods of sustained growth in many low- and middle-income countries that led to some optimism about countries “transitioning” from (i.e. no longer being eligible for) support from the major global health financing mechanisms, such as the Global Fund, Gavi, ...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
July 25, 2023
As the RST builds momentum and scores of countries seek its concessional loans and technical assistance, a new CGD paper, The Resilience and Sustainability Trust: Early Learning and Challenges from Costa Rica and Rwanda, provide early learning from the point of view of lower-income countries themsel...
POLICY PAPERS
July 25, 2023
Demand for the IMF's Resilience and Sustainability Trust (RST) is strong, and the RST is becoming the IMF’s de facto climate finance facility. At the same time, the RST faces a number of challenges, including being far too small to confront climate resilience. Early lessons from RST pilots in Costa...